compounding semaglutide fda Warns Against Using Compounded Novo asks FDA to prevent

It releases inflammatory signals and hormones that can lead to insulin resistance, higher cortisol, and a sluggish metabolic rate

For triple agonist peptides, the most common reports involve the gastrointestinal system: Mild to moderate nausea (especially during the first few weeks)

All included studies reported baseline hormone values and used validated measurement techniques

Patients should be aware that severe, persistent abdominal pain with vomiting could indicate pancreatitis, a rare but serious adverse effect of GLP-1 medications that requires immediate medical attention

It's wise to limit alcohol, as it can heighten side effects such as nausea

The oral form can be a reasonable option for patients who prefer not to self-inject, but clinical expectations should be calibrated accordingly